DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
| MO-AB-225BCD-0 | Joint AAPM-SNMMI Symposium: Nuclear Medicine Theranostics and Functional Image-Guided Radiation Therapy for Precision Oncology S Bowen1*, S Kappadath2*, J Humm3*, S Bentzen4*, D Pafundi5*, (1) University of Washington, School of Medicine, Seattle, WA, (2) UT MD Anderson Cancer Center, Houston, TX, (3) Memorial Sloan-Kettering Cancer Center, New York, NY, (4) University of Maryland, Baltimore, MD, (5) Mayo Clinic, Rochester, MN |
| MO-C930-GePD-F1-3 | Using Gold Nano Particles (GNPs) as a Radiation Sensitizer - A Monte Carlo Simulation Y Chiang*, C Lee , T Chao , Chang Gung University, Guishan Dist, TAO |
| MO-I345-GePD-F4-6 | Determining Institutional Plan Quality Metrics for Intracranial Stereotactic Radiosurgery (SRS) for Single-Isocenter Multi-Target (SIMT) Treatments W Taylor1*, W Zoller2 , M Addington3 , J Palmer4 , R Raval5 , N Sebastian6 , D DiCostanzo7 , (1) ,Ohio State University, Columbus, (2) Ohio State University, Columbus, ,(3) Ohio State University, Columbus, ,(4) Ohio State University, Columbus, ,(5) Ohio State University, Columbus, ,(6) Ohio State University, Columbus, ,(7) Ohio State University Medical Center, Columbus, OH |
| PO-GePV-T-105 | The Application of Fallback Planning in IMPT for Head and Neck Cancers Haijiao Shang/ RaySearch Labs; Yuenan Wang/ CAMS Shenzhen Cancer Hospital |
| PO-GePV-T-107 | Commissioning and Dosimetric Assessment of a Range Shifter Helmet as An Energy Absorber Device for Scanning Beam Proton Therapy B Allred1*, D Mundy2 , K Furutani2 , C Beltran2 , A Saunders1 , S Patel1 , J Rwigema1 , J Shen1 , D Robertson1 , P Lara1 , L McGee1 , M Bues1 , A Anand1 , (1) Mayo Clinic, Phoenix, AZ, (2) Mayo Clinic, Rochester, MN |
| PO-GePV-T-148 | Evaluation of Factors Affecting Absolute Gamma Passing Rates in ArcCHECK Measurements in Tomotherapy C.W. Cheung*, C.W. Kong, H.H.F. Choi, K.Y. Cheung, S.K. Yu, Hong Kong Sanatorium & Hospital, Hong Kong |
| PO-GePV-T-155 | A Multi-Institution Study On the Impact of TG218 QA Tolerance Change On the Tomotherapy DQA Passing Rate T Oldland*, H Shi , S Gerring , W Luo , J Molloy , Q Chen , University of Kentucky, Lexington, KY |
| PO-GePV-T-160 | Comparative Evaluation of Four Commercial Patient-Specific Quality Assurance Devices for Helical Tomotherapy K Chang1*, J Lee2 , J Choi1 , C Hong1 , D Jung1 , J Kim1 , J Kim1 , M Han1 , H Lee1 , D Kim1 , J Kim1 , K Park1 , J Cho1 , Y Kim1 , (1) Yonsei Cancer Center, Seoul, (2) The Catholic University of Korea Incheon ST,MARY' s Hospital ,Incheon, |
| PO-GePV-T-216 | Investigation the Effect of Pitch On Helical Tomotherapy Treaments in Cervical Cancer X Liu*, X Lin , Y Yin , Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong |
| PO-GePV-T-217 | Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Radiotherapy for Cervical Cancer Patients with Ovarian-Conserving Radical Surgery X Liu*, X Lin , Y Yin , Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong |
| PO-GePV-T-279 | One Year Experience with RadCalc Module for Tomotherapy A Kapulsky*, J Napoli , A Ndlovu , Hackensack Univ Medical Center, Hackensack, NJ |
| PO-GePV-T-355 | An Autonomous SBRT Treatment Planning Approach for Patients with Multiple Targets T Wu*, E Pearson , B Aydogan , The University of Chicago, Chicago, IL |
| PO-GePV-T-395 | Alkaline Smart Radiotherapy Biomaterials to Overcome Acidic Tumor Microenvironment M Moreau1*, Z Bashkim2 , W Ngwa3 , (1) Dana Farber Cancer Institute/University of Massachusetts Lowell, Boston, MA, (2) Dana Farber Cancer Institute, Boston, MA, (3) Harvard Medical School, Boston, MA |
| PO-GePV-T-396 | Can Radiation Therapy Enhanced by Cherenkov Photo-Activation (RECA) Elicit a Long-Term Anti-Tumor Effect? S Yoon*, A Rickard , J Adamson , G Palmer , M Oldham , Duke University Medical Center, Durham, NC |
| SU-I400-GePD-F4-1 | Combining Radiotherapy and Nano-Immunotherapy to Boost the Abscopal Effect in Cervical Cancer J Wood1,2*, R Mueller1,3,4 , S Yasmin-Karim1,5 , W Ngwa1,5,6 , (1) Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA (2) University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovakia (3) University Medical Center Mannheim, Heidelberg University, Mannheim, Germany (4) Heidelberg University, Heidelberg, Germany (5) Harvard Medical School, Boston, MA (6) University of Massachusetts Lowell, Lowell, MA |
| SU-I430-GePD-F4-3 | Dosimetric Impact of Prolonged [Y-86]-NM600 PET/CT Imaging for Immunomodulatory Molecular Radiotherapy with [Y-90]-NM600 I Marsh1*, R Hernandez1 , M Turek1 , J Grudzinski1 , J Weichert1 , Z Morris1 , D Vail1 , B Bednarz1 , (1) University of Wisconsin - Madison, Madison, WI |
| SU-L-SAN1-3 | Development of a Novel Delivery Quality Assurance System Based On Simultaneous Verification of Dose Distribution and MLC Movement Using Plastic Scintillator and CCD Camera Y Tanaka1*, M Ishigami2 , T Terazaki3 , M Nakano4 , H Miyauchi4 , T Hasegawa5 , M Hashimoto5 , (1) Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan, (2) Department of Radiology, Kitasato University Hospital, Sagamihara, Japan, (3) Department of Radiation Oncology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan, (4) Cancer Institute Hospital of JFCR, Tokyo, Japan, (5) Faculty of Allied Health Sciences, Kitasato University, Sagamihara, Japan |
| TH-A-225BCD-4 | Adaptive Boosting and Multi-Layer Perceptron Neural Network (ADMLP-NN) for Predicting Real-Time 3D Deformation Field Maps (DFM) for 4D Target Tracking J Pham1*, W Harris2 , W Sun3 , Z Yang4 , F Yin1 , L Ren1 , (1) Duke University Medical Center, Durham, NC, (2) University of Pennsylvania, Philadelphia, PA, (4) Shandong University, Qingdao, China, (5) UT Southwestern Medical Center, Dallas, TX |
| TH-B-SAN4-0 | Immunotherapy Killed the IGRT Star H Al-Hallaq*, S Chmura*, The University of Chicago, Chicago, IL |
| WE-AB-225BCD-7 | Modeling Local Versus Distant Tumor Recurrence in Non-Small Cell Lung Cancer Patients Receiving Combined Chemoradiotherapy and Molecularly Targeted Drugs D McClatchy*, H Paganetti , H Willers , C Grassberger , Massachusetts General Hospital and Harvard Medical School, Boston, MA |
| WE-FG-301-3 | Comparison of Seamless Radiation and Microbeam Radiation in Immunotherapy Enhancement J Rivera1,2*, K Laemont3 , A Tovmasyan4 , S Stryker3 , G Palmer3 , S Chang2 , (1) UNC-Chapel Hill & NC State University, Chapel Hill, NC, (2) UNC-Chapel Hill School of Medicine, Chapel Hill, NC, (3) Duke University School of Medicine, Durham, NC, (4) Duke University Medical Center, Durham, NC |
| WE-FG-301-5 | Immuno-Radiotherapy Targeting Sub-Tumor Volume to Achieve Marginless Radiotherapy (MRT) Inrefractory Prostate Adenocarcinoma S Yasmin-Karim1,2*, M Moreau1,2,4 , J Wood1,2 , P Nguyen1,2 , W Ngwa1,2,3 , (1) Harvard Medical School, Boston, MA, (2) Dana Farber Cancer Institute/University of Massachusetts Lowell, Everett, MA, (3) University of Massachusetts Lowell, Lowell MA 01852 |
| WE-FG-301-9 | Priming the Abscopal Effect - A Lung Cancer Study R Mueller1,2,3*, S Yasmin-Karim3,4 , M Moreau3,4,5 , J Hesser1,2,6,7 , W Ngwa3,4,5 , (1) University Medical Center Mannheim, Mannheim, Germany (2) Heidelberg University, Heidelberg, Germany (3) Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA (4) Harvard Medical School, Boston, MA (5) University of Massachusetts Lowell, Lowell, MA (6) Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany (7) Central Institute for Computer Engineering (ZITI), Heidelberg University, Mannheim, Germany |
| WE-FG-301-11 | Targeted Gold Nanoparticles as Immunostimulators for Radiation Therapy of Triple Negative Breast Cancer N Virani1*, R Berbeco1 , (1) Brigham and Women's Hospital, Dana-Farber Cancer, & Harvard Medical School Boston, MA |
| WE-J-304-4 | Alpha Emitters From TRIUMF A Robertson,1,2, P Schaffer1,2, V Radchenko1,2, C Ramogida1,3, C Hoehr1,2*, (1) TRIUMF, (2) University of British Columbia, Vancouver, BC, (3) Simon Fraser University, Burnaby, Canada |
